$TNDM Piper Sandler raised their target price on shares of Tandem Diabetes Care from $125.00 to $132.00 and gave the company an "overweight" rating in a report on Friday, November 6th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and eleven have assigned a buy rating to the stock. The stock currently has an average rating of "Buy" and a consensus target price of $115.80.
  • 1
1 Like